# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(3.08) per share which missed the analyst consensus estimate of...
Helius Medical Technologies a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance ...
-- The Centers for Medicare & Medicaid Services (CMS) released its preliminary Medicare payment determinations for the PoNS...